ondasdechoque.org
PT-BR

Patellar tendinopathy · Review · 2021

Does adding shockwave to exercise help jumper's knee?

In this review of 37 trials, two trials tested adding shockwave to eccentric (slow-lowering) exercises for jumper's knee. After 12 weeks, pain and knee function were about the same as with sham shockwave plus the same exercises.

Similar to sham with the same exercises
trials in the review
37
trials tested shockwave added to exercise
2
weeks of follow-up
12

Good to know: The review's authors advised against shockwave for jumper's knee.

Challoumas D, Pedret C, Biddle M, et al. BMJ Open Sport & Exercise Medicine, 2021 · Read the paper ↗

How this study worked

2 studiesOne answer
A review gathers earlier studies to answer one question.

Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.

What happened

trials
2
Compared with
Sham shockwave with the same eccentric exercises

Knee pain after 12 weeks

Difference in pain score (VAS) · shockwave + exercise vs sham + exercise

Across two trials, pain after 12 weeks was almost the same whether real or sham shockwave was added to exercise: a difference of 0.1 points.
Show the numbers
Difference (pain score points)likely range
Pain at 12 weeks+0.1−0.8 to 1

What the trials used

ESWT adjunct to eccentric exercise
Two RCTs compared ESWT plus eccentric exercise with sham ESWT plus eccentric exercise at 12 weeks. The accessible narrative does not state device, energy, shock count or sessions; the Figure 3 caption names this two-study network comparison "eccentric exercise–decline squat versus focal extracorporeal shockwave therapy+eccentric exercise". Both groups received eccentric loading, so this is an adjunct comparison, not ESWT alone.

Who took part

Adults with jumper's knee in 37 trials; two trials (shockwave or sham, both with exercise) informed this comparison.

Side effects

The review did not report side effects for shockwave.

All the numbers and the full appraisal

Every reported result

FROM THE FULL PAPER

The results, in numbers.

Adults (>18 years) with clinically diagnosed patellar tendinopathy, any duration/severity. The review included 37 RCTs covering 33 interventions; outcome-specific networks included 16 studies/17 interventions for short-term pain and 19 studies/21 interventions for short-term VISA-P.

Pain during sport preferred where available1 reported outcome
01
12 weeks (short term)

Pain (VAS)

Pain during sport preferred where available MD VAS points (95% CI)

MD0.1CI 95% -0.8 to 1

ESWT+eccentric exercise versus sham ESWT+eccentric exercise; positive favors sham

2 studies

-1Equal results 01.2

Reported estimate and confidence interval.

No statistically significant difference; p=0.84, I²=0%. The review states no clinically important difference.

Analysis details and source

Pooled pairwise estimate from two RCTs; moderate-strength evidence. Both arms received eccentric exercise.

Victorian Institute of Sports Assessment–Patella1 reported outcome
02
12 weeks (short term)

Patellar tendon function (VISA-P)

Victorian Institute of Sports Assessment–Patella MD VISA-P points (95% CI)

MD-1.8CI 95% -8 to 4.4

ESWT+eccentric exercise versus sham ESWT+eccentric exercise; negative favors sham

2 studies

-9.5Equal results 05.9

Reported estimate and confidence interval.

No statistically significant difference; p=0.57, I²=0%. The review states no clinically important difference.

Analysis details and source

Pooled pairwise estimate from two RCTs; moderate-strength evidence.

How treatment was delivered
ESWT adjunct to eccentric exercise

Two RCTs compared ESWT plus eccentric exercise with sham ESWT plus eccentric exercise at 12 weeks. The accessible narrative does not state device, energy, shock count or sessions; the Figure 3 caption names this two-study network comparison "eccentric exercise–decline squat versus focal extracorporeal shockwave therapy+eccentric exercise". Both groups received eccentric loading, so this is an adjunct comparison, not ESWT alone.

HARMS & TOLERABILITY

The accessible article narrative does not provide a pooled ESWT adverse-event result. Do not interpret this as evidence of no harms.

LIMITS OF THE ANALYSIS

All network estimates had low or very low certainty because of high overall risk of bias, imprecision and intransitivity. Only two RCTs informed ESWT+eccentric versus sham+eccentric at 12 weeks; mid-/long-term NMA data were inadequate. ESWT protocol details are not given in the article text; study characteristics are in an online supplement and the network league tables in Figure 4, and neither the supplement nor the figure image was available.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • All network estimates had low or very low certainty because of high overall risk of bias, imprecision and intransitivity. Only two RCTs informed ESWT+eccentric versus sham+eccentric at 12 weeks; mid-/long-term NMA data were inadequate. ESWT protocol details are not given in the article text; study characteristics are in an online supplement and the network league tables in Figure 4, and neither the supplement nor the figure image was available.
Research review

Source-linked critical reading

Systematic review with network meta-analysis

Reading depthMaterial consulted
Technical source record

Read full article, all five figure captions, methods, outcome time stratification, direct two-RCT ESWT comparison, short-term VAS/VISA-P network results, risk of bias, certainty ratings, discussion and recommendations. Supplement tables and figure pixels were unavailable.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review and pairwise/network meta-analysis of randomized studies; searches through May 2021. Thirty-seven RCTs covered 33 interventions. The review used frequentist NMA and GRADE/GRADE-NMA.

Participants

Adults over 18 with clinical patellar tendinopathy of any duration or severity were eligible. Sport type/level and prior treatment varied. Outcome networks were smaller than the full set of 37 trials.

Intervention

Two RCTs tested ESWT added to eccentric exercise against sham ESWT with the same eccentric exercise. Device, energy, shock count and session details are not stated in accessible narrative.

Comparator

The direct comparator was sham ESWT, with eccentric exercise in both groups. Across the network, sham/placebo was treated as no treatment.

Outcomes

Primary outcome was pain VAS (sports pain preferred where reported); VISA-P was secondary. At 12 weeks, pooled differences were pain MD +0.1 (95% CI −0.8 to 1.0) and VISA-P MD −1.8 (−8.0 to 4.4), with no statistical or clinical difference.

Comparative findings

The direct pairwise evidence was moderate strength and found no short-term advantage of adding ESWT. NMA rankings favored other regimens for short-term outcomes but were low/very low certainty; mid/long-term NMA data were inadequate. The authors recommended against ESWT.

Harms

No pooled ESWT harm estimate was provided in accessible narrative; absence of a reported estimate is not evidence of no harm.

Limitations

Most included studies had high/unclear risk of bias, networks were sparse, and rankings were limited by imprecision and intransitivity. The online supplement with study-level characteristics and the Figure 4 league-table image were unavailable.

Applicability

The findings apply to patellar tendinopathy and the studied adjunct comparison. They do not establish that all ESWT protocols are identical, but the review does not support adding ESWT to eccentric exercise at 12 weeks.

Research needs

Trials should report device, energy, session details, harms, validated outcomes and prespecified short-, mid- and long-term follow-up, with adequate sample sizes and low risk of bias.

THE ORIGINAL SOURCE

Read the original article.

Management of patellar tendinopathy: a systematic review and network meta-analysis of randomised studies.

Challoumas D, Pedret C, Biddle M, Ng NYB, Kirwan P, Cooper B, Nicholas P, Wilson S, Clifford C, Millar NL. · BMJ open sport & exercise medicine · 2021

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →